Tetracosactide
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
H01AA02
CAS registry number (Chemical Abstracts Service)
0016960-16-0
Chemical Formula
C136-H210-N40-O31-S
Molecular Weight
2933
Therapeutic Category
Analogue of adrenocorticotropic hormone (ACTH)
Chemical Name
α¹-²⁴-Corticotropin
Foreign Names
- Tetracosactidum (Latin)
- Tetracosactid (German)
- Tétracosactide (French)
- Tetracosactida (Spanish)
Generic Names
- Cosyntropin (OS: USAN)
- Tetracosactide (OS: BAN, DCIT)
- Tétracosactide (OS: DCF)
- Ciba 30920 Ba (IS)
- Corticotropin tetracosapeptide (IS)
- Tetracosactrin (IS)
- Tetracosactid (PH: Ph. Eur. 8)
- Tetracosactide (PH: BP 2016, Ph. Eur. 8)
- Tétracosactide (PH: Ph. Eur. 8)
- Tetracosactidum (PH: Ph. Eur. 8)
- Tetracosactide Acetate (OS: BANM, JAN)
- Tetracosactidi hexaacetas (IS)
- Tetracosactrin Acetate (IS)
- Cosyntropin zinc hydroxide (IS)
- Tetracosactrin Zinc Injection (PH: BP 2013)
Brand Names
- Cortrosyn
Amphastar, Canada; Amphastar, United States - Cosyntropin Sandoz
Sandoz, United States - Synachten
Novartis, Lebanon - Synachten Retard
Novartis, Lebanon - Synacthen
Novartis, Colombia; Novartis, Turkey; Sanolabor, Slovenia - Synacthen Depot
Novartis, Egypt; Sigma-Tau Industrie Farmaceutiche Riunite, Austria - Synacthen-depot
Novartis, Turkey - Synacthene
IFET, Greece - Synacthène
Sigma-Tau, France - Synacthene Depot
IFET, Greece - Synacthene Retard
IFET, Greece - Synacthène Retard (Tetracosactide and Zinc Chloride)
Sigma-Tau, France - Cortrosyn
Daiichi Sankyo, Japan - Cortrosyn Z
Daiichi Sankyo, Japan - Nuvacthen
Defiante Farmaceutica S.A., Spain - Nuvacthen Depot
Defiante Farmaceutica S.A., Spain - Synachten Depot
Novartis, Romania - Synacthen
Biofutura Pharma, Italy; CD Pharma, Denmark; Defiante, Netherlands; Mallinckrodt, Switzerland; MPCA, Belgium; Novartis, Argentina; Novartis, New Zealand; Novartis Pharmaceuticals, Australia; Questcor Operations, United Kingdom; Sigma-tau, Germany; Sigma-Tau Industrie Farmaceutiche Riunite, Austria; Swedish Orphan Biovitrum Ltd., Ireland - Synacthen Depot
Defiante, Portugal; Mallinckrodt, Switzerland; Novartis, New Zealand; Novartis, Oman; Novartis AH, South Africa; Nycomed, Israel; Questcor Operations, United Kingdom; Sigma-tau, Germany; MPCA, Belgium; Novartis, Chile; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
